Cite
HARVARD Citation
Donken, R. et al. (2020). Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial. Clinical infectious diseases. pp. 1022-1029. [Online].